NIH-funded research Fellowship grant

Investigating genetic variations linked to autism in brain cells

Official title: Cell-type specific and activity-dependent characterization of non-coding autism de novo variants in human stem cell-derived neurons

Funded at Icahn School of Medicine at Mount Sinai · NIH-11065514 · Data updated 2026-11-12

This study is looking at how certain genetic changes might affect brain cells and contribute to autism, with the hope of finding better ways to diagnose and treat people with autism.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionIcahn School of Medicine at Mount Sinai
NIH-funded
Lab location1 site (New York, United States)
Project startApril 24, 2023
Project endApril 23, 2026
Funding year2025
Award (this year)$48,974
NIH project number5F31MH133365-03
Project IDNIH-11065514 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are children aged 0-11 years who have been diagnosed with autism spectrum disorder.

Less likely to help

Patients who do not have autism spectrum disorder or are older than 11 years may not benefit from this research.

What this research studies

This research focuses on understanding how specific genetic changes, known as de novo variants, contribute to autism spectrum disorder (ASD) by examining their effects in different types of brain cells derived from human stem cells. The researchers will analyze non-coding regions of the genome, which have been less studied but may play a crucial role in the disorder. By using advanced techniques to activate these cells, they aim to uncover how these genetic variants influence brain function and behavior. This could lead to better diagnostic tools and treatments for individuals with ASD.

Why it matters

Potential benefit: If successful, this research could enhance our understanding of autism and lead to improved therapies and diagnostic methods for affected individuals.

How similar studies have gone: Previous research has shown promise in understanding genetic contributions to autism, but this approach focusing on non-coding variants is relatively novel.

Where this research is happening

  • Icahn School of Medicine at Mount Sinai
    New York, United States
    Active

Researchers

  • Principal investigator: Williams, Sarah Elizabeth — Icahn School of Medicine at Mount Sinai
  • Study coordinator: Williams, Sarah Elizabeth

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.